Postpartum Haemorrhage — FRCA Final MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Carboprost 250 micrograms IM
Explanation lettering: E = shown as B · B = shown as C · C = shown as D · D = shown as E
Carboprost (A) is correct. It is a 15-methyl prostaglandin F2-alpha analogue acting at myometrial FP receptors via Gq–phospholipase C–IP3, raising intracellular calcium and producing sustained uterine contraction. UK guidance lists carboprost 250 micrograms IM, repeatable at intervals of 15 minutes or more to a maximum of eight doses, for atony persisting after oxytocin, ergometrine and misoprostol; bronchoconstriction makes asthma a key caution, excluded here. Ergometrine (B) has already been given and repeat dosing is not advised, with added hypertensive and emetic risk. Tranexamic acid (C) is an essential antifibrinolytic adjunct but is not a uterotonic and should only be repeated after at least 30 minutes. Adrenaline (D) is for cardiac arrest or anaphylaxis, not atony. Desmopressin (E) is reserved for von Willebrand disease or uraemic platelet dysfunction.
Reference: NICE, Intrapartum care (NG235) — Management of postpartum haemorrhage, visual summary (uterotonic options including carboprost 250 micrograms IM), 2023. https://www.nice.org.uk/guidance/ng235/resources/management-of-postpartum-haemorrhage-visual-summary-pdf-13187003437